|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 3237001 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15823805.5 |
| Date of filing the European patent application | 2015-12-21 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
| (46) | Date of publication of the claims translation | 2024-04-25 |
| (86) | Number | PCT/IB2015/059836 |
| Date | 2015-12-21 |
| (87) | Number | WO 2016/103153 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462095210 P | 2014-12-22 | US |
| (72) |
JOERG, Susanne , CH
SERNO-SCHERSCH, Kathrin , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmaciniai produktai ir stabilios skystos IL-17 antikūnų kompozicijos |
| PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 10 | 231.00 EUR |
| 2025-12-21 |